Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

A blood test for more than 50 types of cancer could help speed up diagnosis, according to a new study. Results of a trial in ...

Fran Curtis is a five-time survivor of cancers survivor including breast, appendix and skin cancer, but she told CURE in a ...

A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

A new non-hormonal platelet rich plasma injection may help women with breast cancer ease menopause symptoms like UTIs, ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive surgeries, difficult therapies ...

One woman who suffered debilitating symptoms for 14 years before she finally received a diagnosis described the news as 'life ...

GE HealthCare Chief AI Officer Parminder Bhatia discusses medtech artificial intelligence development, safety and regulations ...

Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo1IMvigor011 is the first global phase III study to read out pioneering a ctDNA- guide ...

The report ‘Prostate Cancer Screening: The Impact on the NHS’ was published by Prostate Cancer Research at 00:01 UK time on Tuesday 14 October 2025.